Osaic Holdings’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24 | Buy |
+113
| New | +$24 | ﹤0.01% | 7165 |
|
|
2025
Q1 | – | Sell |
-113
| Closed | -$24 | – | 7568 |
|
|
2024
Q4 | $24 | Sell |
113
-919
| -89% | -$195 | ﹤0.01% | 7137 |
|
|
2024
Q3 | $2.22K | Hold |
1,032
| – | – | ﹤0.01% | 6399 |
|
|
2024
Q2 | $5.32K | Sell |
1,032
-53
| -5% | -$273 | ﹤0.01% | 6037 |
|
|
2024
Q1 | $5.8K | Buy |
1,085
+2
| +0.2% | +$11 | ﹤0.01% | 5920 |
|
|
2023
Q4 | $8.44K | Buy |
1,083
+787
| +266% | +$6.13K | ﹤0.01% | 5867 |
|
|
2023
Q3 | $1.17K | Buy |
296
+73
| +33% | +$288 | ﹤0.01% | 6637 |
|
|
2023
Q2 | $702 | Hold |
223
| – | – | ﹤0.01% | 6830 |
|
|
2023
Q1 | $594 | Hold |
223
| – | – | ﹤0.01% | 6965 |
|
|
2022
Q4 | $1K | Sell |
223
-510
| -70% | -$2.29K | ﹤0.01% | 6923 |
|
|
2022
Q3 | $4K | Buy |
733
+90
| +14% | +$491 | ﹤0.01% | 6478 |
|
|
2022
Q2 | $6K | Buy |
643
+313
| +95% | +$2.92K | ﹤0.01% | 6390 |
|
|
2022
Q1 | $3K | Buy |
330
+86
| +35% | +$782 | ﹤0.01% | 6657 |
|
|
2021
Q4 | $8K | Buy |
244
+200
| +455% | +$6.56K | ﹤0.01% | 6349 |
|
|
2021
Q3 | $1K | Hold |
44
| – | – | ﹤0.01% | 7028 |
|
|
2021
Q2 | $3K | Buy |
44
+4
| +10% | +$273 | ﹤0.01% | 6592 |
|
|
2021
Q1 | $3K | Buy |
40
+30
| +300% | +$2.25K | ﹤0.01% | 6348 |
|
|
2020
Q4 | $1K | Sell |
10
-55
| -85% | -$5.5K | ﹤0.01% | 6185 |
|
|
2020
Q3 | $6K | Hold |
65
| – | – | ﹤0.01% | 5486 |
|
|
2020
Q2 | $7K | Hold |
65
| – | – | ﹤0.01% | 5303 |
|
|
2020
Q1 | $4K | Buy |
+65
| New | +$4K | ﹤0.01% | 5403 |
|